Perindopril Erbumine
Product Images NDC 68180-235

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Perindopril Erbumine (NDC 68180-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Perindopril Erbumine Structural Formula (Fbb31482 9ac8 48c6 B814 5d467f22051b 01)

Chemical structure of Perindopril Erbumine showing its molecular components including the carboxylic acid group, nitrogen-containing ring, and associated side chains, alongside the triethylamine component.*

FDA Label Image

Figure 1. (Fbb31482 9ac8 48c6 B814 5d467f22051b 02)

A line graph comparing the proportion of patients who experienced cardiovascular mortality, non-fatal myocardial infarction, or cardiac arrest over a 5-year period between those treated with Perindopril and those given a placebo. The graph includes error bars and a table showing the number of patients at risk for each group at different time points. Perindopril shows a lower event proportion than placebo.*

FDA Label Image

Figure 2 (Fbb31482 9ac8 48c6 B814 5d467f22051b 03)

A forest plot chart displaying the primary event percentages in patients treated with Perindopril versus placebo across various subgroups, including gender, age, medical history, and medication use. The x-axis shows a scale favoring Perindopril on the left and placebo on the right. Data points with confidence intervals are plotted for each subgroup comparing Perindopril and placebo event rates.*

FDA Label Image

Perindopril Erbumine Tablets, 2 mg. (Fbb31482 9ac8 48c6 B814 5d467f22051b 04)

Perindopril Erbumine Tablets 2 mg label showing a package containing 100 tablets. The label includes the NDC code 68180-235-01, states that each tablet contains 2 mg of perindopril erbumine, and notes the product is Rx only. Manufactured for Lupin Pharmaceuticals, Inc. and by Lupin Limited in India. Storage instructions and a barcode are also visible.*

FDA Label Image

Perindopril Erbumine Tablets, 4 mg. (Fbb31482 9ac8 48c6 B814 5d467f22051b 05)

Perindopril Erbumine Tablets 4 mg label from Lupin Pharmaceuticals, Inc. The label states each tablet contains 4 mg of perindopril erbumine. The package contains 100 tablets. Storage instructions include keeping out of reach of children and storing at 20° to 25°C. Manufactured by Lupin Limited in Goa, India.*

FDA Label Image

Perindopril Erbumine Tablets, 8 mg. (Fbb31482 9ac8 48c6 B814 5d467f22051b 06)

Perindopril Erbumine Tablets 8 mg label showing the drug name, strength, and dosage form. The label indicates a package size of 100 tablets, manufactured for Lupin Pharmaceuticals, Inc. and by Lupin Limited in Goa, India. Storage instructions specify keeping at controlled room temperature between 20° to 25°C (68° to 77°F) and protecting from moisture. The label includes a barcode and the NDC number 68180-237-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.